Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 105 peer-reviewed journal articles Updated
Hematology

Essential Thrombocythemia (ET) Patient Guide

At a Glance

Essential thrombocythemia (ET) is a rare blood cancer that requires specialized management. This patient guide helps you understand your diagnosis, decode bone marrow pathology results, assess your personal risks, and partner effectively with your hematology team for long-term health.

Welcome to your comprehensive guide to Essential Thrombocythemia (ET). Being diagnosed with a rare blood cancer can be an isolating and overwhelming experience. This resource is designed to help stop the panic spiral, decode the complex medical jargon, and empower you to become an active, informed partner in your own healthcare.

In this guide, you will find evidence-based information broken down into the key areas of your patient journey:

01

Understanding Your Diagnosis: The Basics of ET

Recently diagnosed with Essential Thrombocythemia (ET)? Learn the basics of this chronic blood cancer, including life expectancy, risks, and treatment goals.

02

Symptoms and Warning Signs: What to Watch For

Learn the common symptoms and critical warning signs of Essential Thrombocythemia (ET). Understand erythromelalgia, AVWS bleeding risks, and when to seek care.

03

Diagnosis and Pathology: Understanding Your Results

Learn how to read your Essential Thrombocythemia (ET) pathology report. Understand bone marrow biopsy results, genetic mutations, and fibrosis grading.

04

The Genetics of ET: Understanding Your Mutations

Understand the genetics of Essential Thrombocythemia (ET). Learn how JAK2, CALR, MPL, and triple-negative mutations impact your platelet count and clot risk.

05

Knowing Your Risk: The IPSET-Thrombosis Score

Learn how the IPSET-Thrombosis score calculates blood clot risk in Essential Thrombocythemia (ET). Understand how age, JAK2, and medical history guide treatment.

06

Treatment Strategies: Managing Your Risk

Discover treatment strategies for Essential Thrombocythemia (ET). Learn how risk categories guide the use of aspirin, Hydroxyurea, Pegasys, and Anagrelide.

07

Living with ET: Monitoring and Long-Term Health

Learn how to manage Essential Thrombocythemia (ET) long-term. Understand routine CBC monitoring, red flags for disease progression, and cardiovascular health.

Take your time reading through these pages. You do not have to absorb everything at once. Bookmark this page and return to it as your journey with ET evolves. Use the reflection questions and the specialized questions for your doctor provided at the end of each page to help you prepare for productive, empowering appointments with your hematology team.

Common questions in this guide

What is Essential Thrombocythemia (ET)?
Essential Thrombocythemia (ET) is a rare blood cancer where the body overproduces blood platelets. It requires ongoing monitoring and specialized care from a hematology team to manage risks like blood clots.
What should I ask my doctor after an ET diagnosis?
It is important to ask your hematologist which health metrics and symptoms you should be focusing on right now. You should also establish a clear communication plan for when new symptoms arise between your scheduled appointments.
What is the IPSET-Thrombosis score used for?
The IPSET-Thrombosis score is a medical tool used to evaluate your individual risk of developing blood clots. Your hematologist uses this score to create a personalized, safe treatment strategy for your ET.
How can I keep track of my ET lab results?
Always ask your medical team for printed copies or patient portal access to all your lab reports and bone marrow pathology results. Having your own copies helps you stay informed and empowered in your healthcare journey.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the most important health metric or symptom I should focus on right now?
  2. 2.How should we communicate between appointments if I experience a new symptom?
  3. 3.Can you provide me with printed copies or portal access to all my lab reports and bone marrow pathology results?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide provides an educational overview of Essential Thrombocythemia (ET). It is not a substitute for professional medical advice, diagnosis, or treatment from your hematologist.

Get notified when new evidence is published on Essential thrombocythemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.